Help Cure Mesothelioma Cancer Forever

(PRLEAP.COM) It only takes your decision to take action to helping create and fund a $30 million per year federal program that will save the lives of thousands of people.

The Mesothelioma Applied Research Foundation, Inc., or MARF, has been created to raise funds for research on new therapies for malignant mesothelioma cancer.

Asbestos Mesothelioma is a cancer that affects thousands each year. The fatal disease appears in the form of a malignant tumor that aggressively invades the linings of the lungs, abdomen, heart or testicles.

Excessive exposure to asbestos seems to be one of the reasons that create Mesothelioma. Unfortunately research for the cancer is currently under funded, but with your help that is all about to change.

http://cure-mesothelioma-cancer.info

It only takes your decision to take action and to sign a petition online to help generate $30 million in federal money for the National Mesothelioma Research and Treatment Program.

The main focus of the program is the early detection and prevention of mesothelioma cancer. To ensure that a cure is discovered and to help those that are already affected by the disease it targets also different areas of therapeutic research and education.

Discover how you can help save the lives of thousands of people across America and help find a cure for this cancer forever.

For additional information visit:

http://cure-mesothelioma-cancer.info/fight-mesothelioma.html
Contact Information
Marcus Schroefel
MS-Publishing
+49 6131 6262906
Email MS-Publishing

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

Share this News
PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy